Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin add-on therapy for glycemic variability and hypoglycemia in adults with type 1 diabetes
ChiCTR-IPR-17014103Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of saxagliptin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Mean amplitude of glycemic excursions. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
saxagliptin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ChiCTR-IPR-17014103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014103.